FORESIGHT BIOTHERAPEUTICS

foresight-biotherapeutics-logo

Foresight Biotherapeutics is a clinical-stage drug development company pioneering novel therapies designed to address significant unmet needs in ophthalmology and otolaryngology. Foresightโ€™s platform Povidone-Iodine (PVP-I) technology represents an important breakthrough in the treatment of ocular and otic inflammation including bacterial, viral and fungal infections. This platform enables PVP-I, a well-characterized broad spectrum antiseptic with no known microbial resistance, to be formulated in combination with a range of anti-inflammatory agents.

#People #Financial #Website #More

FORESIGHT BIOTHERAPEUTICS

Industry:
Biotechnology Health Diagnostics Therapeutics

Founded:
2008-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.foresightbio.com

Total Employee:
1+

Status:
Active

Contact:
646-747-9100

Email Addresses:
[email protected]

Total Funding:
17 M USD

Technology used in webpage:
Domain Not Resolving


Current Employees Featured

not_available_image

Stephen C. Rocamboli
Stephen C. Rocamboli Director @ Foresight Biotherapeutics
Director

not_available_image

Michael Weiser
Michael Weiser Director and Co-Founder @ Foresight Biotherapeutics
Director and Co-Founder

Founder


not_available_image

Michael Weiser

Investors List

integrin-partners_image

Integrin Partners

Integrin Partners investment in Venture Round - Foresight Biotherapeutics

Official Site Inspections

http://www.foresightbio.com

Unable to get host informations!!!

Loading ...

More informations about "Foresight Biotherapeutics" on Search Engine